In part 5 of this Exclusive Interview, Mark Peyrot talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, CA about the importance of talking with their patients to assess the state of their feelings about their diabetes management.

So often in patients with diabetes, there are multiple co-morbidities that can lead to premature death or at the least a decreased quality of life. There is often the question as to which disease comes first and whether the combination of these diseases worsen each other. This week, our Clinical …

Young man, 21 years of age. type 1 diabetes since 9 years of age. Has not been to see hcp for a year. States he doesn’t like people interrogating him, but came in because he needs his insulin. States he doesn’t check his glucose because he can tell what it is. Tired of having type 1 diabetes and tired of checking numbers. A1C in office--10.2%.

In part 3 of this Exclusive Interview, Dr. Ray Kausik talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 convention in San Diego, CA about work toward lowering the risk of cardiovascular death.

In this week's Homerun Slides, the genetics of diabetes and the implications for beta cells.

Introduction: An association between hyperglycemia, diabetes, and cancer has been recognized for many years. Epidemiologists first noted the association between diabetes and cancer in the early part of the twentieth century, while the association between hyperglycemia and cancer was reported in 1885. At that time, in Europe and North America life expectancy was improving, rates of over-nutrition and under-exercise were increasing, there was a rise in the percentage of people that were overweight, and the incidence of diabetes began to climb.

The answer comes from a mediation analysis of the EMPA-REG OUTCOME Trial.

Higher score measuring severity of pain indicated elevated treatment failure risk.

Young patients with low BMIs, C-peptide levels, and significant symptoms at onset of diabetes at higher risk of undergoing rapid C-peptide decline.

Patients are not seeing the expected results because of medication adherence.